Central African Republic vs Democratic Republic of Congo: The number of people with susceptibility test result for rifampicin
Central African Republic
9.75
in 2021
Democratic Republic of Congo
22.3
in 2021
Central African Republic rank
139th
Democratic Republic of Congo rank
136th
The number of people with susceptibility test result for rifampicin over time
- Central African Republic
- Democratic Republic of Congo
How they compare
Democratic Republic of Congo currently reports 22.3 against 9.75 in Central African Republic, a difference of 12.55.
That makes Democratic Republic of Congo's figure about 2.3 times Central African Republic's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Democratic Republic of Congo ahead.
Central African Republic ranks 139th and Democratic Republic of Congo ranks 136th of 146 countries.
Democratic Republic of Congo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.64 | 4.66 | 3.02 | Democratic Republic of Congo |
| 2020s | 10.12 | 15.68 | 5.56 | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or Democratic Republic of Congo?
- Democratic Republic of Congo, at 22.3 against 9.75 in Central African Republic as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and Democratic Republic of Congo?
- 12.55, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Central African Republic and Democratic Republic of Congo?
- 5 years are reported by both, from 2017 to 2021.
- How do Central African Republic and Democratic Republic of Congo rank globally for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 139th and Democratic Republic of Congo ranks 136th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.